Does advanced therapy for pulmonary arterial hypertension reduce the risk of death in adults with Eisenmenger syndrome?
Advanced therapy for pulmonary arterial hypertension in adults with Eisenmenger syndrome is associated with improved survival, hemodynamics, and functional class.
AT for pulmonary arterial hypertension in a contemporary cohort of adults with Eisenmenger syndrome was associated with a lower risk of death. Survival benefits should be considered together with improved hemodynamics and functional class when decisions are made about AT in this population.
Dimopoulos et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: